| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |